Idexx Laboratories [IDXX] vs Waters [WAT] Detailed Stock Comparison

Idexx Laboratories, Inc.

NASDAQ
Loading...

Waters Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Idexx Laboratories, Inc. wins in 10 metrics, Waters Corporation wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Idexx Laboratories, Inc. Waters Corporation Better
P/E Ratio (TTM) 42.92 28.90 Waters Corporation
Price-to-Book Ratio 27.85 7.24 Waters Corporation
Debt-to-Equity Ratio 60.83 60.28 Waters Corporation
PEG Ratio 2.41 -9.39 Idexx Laboratories, Inc.
EV/EBITDA 31.12 28.78 Waters Corporation
Profit Margin (TTM) 24.62% 20.30% Idexx Laboratories, Inc.
Operating Margin (TTM) 29.76% 33.76% Waters Corporation
EBITDA Margin (TTM) 29.76% 33.76% Waters Corporation
Return on Equity 66.20% 29.28% Idexx Laboratories, Inc.
Return on Assets (TTM) 25.59% 11.52% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $1.04B $539.81M Idexx Laboratories, Inc.
1-Year Return 7.30% 3.87% Idexx Laboratories, Inc.
Price-to-Sales Ratio (TTM) 10.38 9.65 Waters Corporation
Enterprise Value $46.85B $31.49B Idexx Laboratories, Inc.
EV/Revenue Ratio 10.89 9.95 Waters Corporation
Gross Profit Margin (TTM) 60.35% 61.08% Waters Corporation
Revenue per Share (TTM) $54 $53 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $13.07 $10.77 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.72 1.20 Waters Corporation
Short % of Float 2.74% 3.38% Idexx Laboratories, Inc.

Idexx Laboratories, Inc. vs Waters Corporation Stock Performance Analysis

Loading Price Chart...

IDXX
WAT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%
Waters Corporation0.63%-1.54%8.67%23.36%-7.18%-6.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%
Waters Corporation3.87%32.07%3.74%165.28%286.07%736.74%

Performance & Financial Health Analysis: Idexx Laboratories, Inc. vs Waters Corporation

MetricIDXXWAT
Market Information
Market Cap i$44.66B$30.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i480,502809,747
90 Day Avg. Volume i516,114944,136
Last Close$570.00$357.76
52 Week Range$506.91 - $769.98$275.05 - $414.15
% from 52W High-25.97%-13.62%
All-Time High$769.98 (Nov 26, 2025)$428.22 (Sep 06, 2021)
% from All-Time High-25.97%-16.45%
Growth Metrics
Quarterly Revenue Growth0.14%0.07%
Quarterly Earnings Growth0.15%-0.03%
Financial Health
Profit Margin (TTM) i0.25%0.20%
Operating Margin (TTM) i0.30%0.34%
Return on Equity (TTM) i0.66%0.29%
Debt to Equity (MRQ) i60.8360.28
Cash & Liquidity
Book Value per Share (MRQ)$20.14$43.01
Cash per Share (MRQ)$2.26$5.99
Operating Cash Flow (TTM) i$1.18B$652.56M
Levered Free Cash Flow (TTM) i$790.74M$427.16M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Idexx Laboratories, Inc. vs Waters Corporation

MetricIDXX (Apr 24, 2026)WAT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i42.9228.90
Forward P/E i34.1919.04
PEG Ratio i2.41-9.39
Price to Sales (TTM) i10.389.65
Price to Book (MRQ) i27.857.24
Market Capitalization
Market Capitalization i$44.66B$30.55B
Enterprise Value i$46.85B$31.49B
Enterprise Value Metrics
Enterprise to Revenue i10.899.95
Enterprise to EBITDA i31.1228.78
Risk & Other Metrics
Beta i1.721.20
Book Value per Share (MRQ) i$20.14$43.01

Financial Statements Comparison: Idexx Laboratories, Inc. vs Waters Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIDXX (2025)WAT (2025)
Revenue/Sales i4.30B3.17B
Cost of Goods Sold i1.64B1.29B
COGS % of Revenue i38.2%40.7%
Gross Profit i2.66B1.88B
Gross Margin i61.8%59.3%
Research & Development i251.21M195.71M
Operating Income (EBIT) i1.36B802.59M
Operating Margin i31.6%25.4%
EBITDA i1.51B1.03B
EBITDA Margin i35.0%32.6%
Pre-Tax Income i1.32B754.88M
Pre-Tax Income % of Revenue i30.8%23.8%
Income Tax i264.73M112.25M
Income Tax % of Revenue i6.2%3.5%
Net Income (Profit) i1.06B642.63M
Profit Margin i24.6%20.3%

Balance Sheet & Liquidity Metrics

MetricIDXX (2025)WAT (2025)
Cash & Equivalents i180.07M587.83M
Total Current Assets i1.41B2.15B
Total Current Assets % of Revenue i32.9%67.8%
Total Current Liabilities i1.15B1.24B
Total Current Liabilities % of Revenue i26.7%39.2%
Long-Term Debt i475.99M999.99M
Long-Term Debt % of Revenue i11.1%31.6%
Total Shareholders Equity i1.61B2.56B
Retained Earnings i6.39B10.43B
Retained Earnings % of Revenue i148.5%329.6%
Property, Plant & Equipment i123.23M824.49M

Cash Flow Statement Comparison

MetricIDXX (2025)WAT (2025)
Operating Cash Flow i1.17B652.56M
Operating Cash Flow % of Revenue i27.3%20.6%
Capital Expenditures i-124.68M-112.75M
Free Cash Flow i1.04B539.81M
FCF Margin i24.2%17.1%
Debt Repayment i-428.39M-290.00M
Common Stock Repurchase i-1.22B-14.67M

Short Interest & Institutional Ownership Analysis

MetricIDXXWAT
Shares Short i1.91M3.32M
Short Ratio i3.852.98
Short % of Float i2.74%3.38%
Shares Outstanding i79.71M59.55M
Float Shares i78.75M97.96M
% Held by Insiders i0.71%0.11%
% Held by Institutions i96.04%63.35%
% Held by Public i3.25%36.54%

Dividend Analysis & Yield Comparison: Idexx Laboratories, Inc. vs Waters Corporation

MetricIDXXWAT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A